Drugs for Neglected Diseases Initiative Fondation

Drugs for Neglected Diseases Initiative Fondation is an organisation in Geneve, Switzerland that has taken part in 10 EU-funded projects since 2009, receiving €4.3M in EU funding and leading 1 as coordinator.

EU funding received€4.3M
EU projects10
As coordinator1
Running now6
First EU project2009
Latest project2025
CountrySwitzerland
EU registration (PIC)992772012
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Drugs for Neglected Diseases Initiative Fondation's own share of each project, not the project's full budget.

  • Horizon 2020€2.3M · 1 project
  • FP7 (2007 to 2013)€1.7M · 2 projects
  • Horizon Europe€227k · 7 projects

Projects

10 EU-funded projects, newest first. Drugs for Neglected Diseases Initiative Fondation led 1 of them as coordinator. Each links to the official record.

  • IVM-KIDSAssociated partner

    Accelerating a paediatric formulation of ivermectin for the control of Neglected Tropical Diseases

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • FAMEAssociated partner

    REPURPOSING FUSIDIC ACID AS A SHORT-COURSE ONCHOCERCA VOLVULUS MACROFILARICIDE: A RANDOMIZED CONTROLLED OPEN-LABEL PARALLEL GROUP INTERVENTION PHASE IIA/B PILOT TRIAL

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • RISE-ARBBAssociated partner

    Enhancing the Risk Stratification of Severe Arboviral diseases using host-response Biomarkers in Brazil.

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • WINGS-4-FGSAssociated partner

    (W)Initiative for womeN and GirlS affected by Female Genital Schistosomiasis

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • STROGHATAssociated partner

    Stop transmission of gambiense human African trypanosomiasis

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • eWHORMAssociated partner

    Enabling the WHO-Roadmap 2030

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • END-VOCPartner

    ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €227ktheir share
  • HELPPartner

    Collaboration for innovation: Establishment of a pan-nematode drug development platform

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €2.3Mtheir share
  • AfriCoLeishCoordinator

    Care Package for Treatment and Control of Visceral Leishmaniasis in East Africa

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €1.5Mtheir share
  • LEISHDNAVAXPartner

    Development of a DNA vaccine for visceral leishmaniasis

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €254ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • alkali metals
  • artificial intelligence
  • drug discovery
  • mathematical model
  • oncology
  • pharmaceutical drugs
  • pharmacokinetics
  • pharmacology and pharmacy
  • public health
  • sexual health
  • toxicology
  • tropical medicine

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime